United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new stake in Cigna Group (NYSE:CI – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 123,888 shares of the health services provider’s stock, valued at approximately $34,098,000.
A number of other large investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after buying an additional 4,738 shares during the last quarter. Providence Capital Advisors LLC grew its position in shares of Cigna Group by 1,016.8% in the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after buying an additional 7,748 shares during the last quarter. Caprock Group LLC acquired a new stake in Cigna Group during the 3rd quarter worth $4,124,000. National Pension Service boosted its stake in Cigna Group by 3.2% during the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after purchasing an additional 21,203 shares during the period. Finally, Banco Bilbao Vizcaya Argentaria S.A. boosted its stake in Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.
Cigna Group Stock Down 0.4%
CI stock opened at $284.62 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The stock has a market capitalization of $75.29 billion, a PE ratio of 12.07, a price-to-earnings-growth ratio of 1.03 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company has a fifty day moving average of $278.07 and a 200-day moving average of $276.88.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.
Insider Transactions at Cigna Group
In related news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 205,904 shares of company stock worth $60,277,068. Company insiders own 0.60% of the company’s stock.
Wall Street Analysts Forecast Growth
CI has been the subject of a number of recent research reports. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Guggenheim increased their price target on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. UBS Group increased their price target on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Mizuho set a $330.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Finally, TD Cowen increased their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $339.50.
Read Our Latest Stock Analysis on CI
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
